NIH

Study: Increased aerosol transmission for B.1.1.7 (alpha variant) over lineage A variant of SARS-CoV-2. Image Credit: NIAID

NIH scientists demonstrate efficient aerosol transmission of SARS-CoV-2 in hamsters

Researchers in the United States have demonstrated the efficient aerosol transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – in a hamster model. The team from the National Institute of Allergy and Infectious Diseases in Hamilton, Montana, specifically designed novel transmission cages to investigate aerosol …

NIH scientists demonstrate efficient aerosol transmission of SARS-CoV-2 in hamsters Read More »

University of Louisville receives NIH funding to support research into liver-related illness

University of Louisville receives NIH funding to support research into liver-related illness

The University of Louisville Hepatobiology and Toxicology Center of Biomedical Research Excellence (COBRE) has received $11.3 million in funding from the National Institutes of Health (NIH) to support its research into liver-related illness for an additional five years. The UofL Hepatobiology and Toxicology (H&T) Center was created in 2016 with an $11.5 million grant from …

University of Louisville receives NIH funding to support research into liver-related illness Read More »

UC Davis Clinical Translational Science Center receives its third NIH award renewal

UC Davis Clinical Translational Science Center receives its third NIH award renewal

The UC Davis Clinical Translational Science Center received notice of its third National Institutes of Health (NIH) award renewal, a vote of confidence in the center’s ability to advance outstanding research in human health. The 5-year award, almost $33 million, comes from NIH’s National Center for Advancing Translational Science (NCATS). It provides critical funding to …

UC Davis Clinical Translational Science Center receives its third NIH award renewal Read More »

NYITCOM researcher receives NIH grant to explore the effect of stress on clinical depression

NYITCOM researcher receives NIH grant to explore the effect of stress on clinical depression

A researcher at New York Institute of Technology College of Osteopathic Medicine (NYITCOM) has secured a grant from the National Institutes of Health (NIH) to study how certain brain cells respond to chronic stress. The project is estimated to receive $1.6 million over five years and could help to identify breakthrough treatments for clinical depression, …

NYITCOM researcher receives NIH grant to explore the effect of stress on clinical depression Read More »

Large NIH Clinical Trial Will Test Polyclonal Antibody Therapeutic for COVID-19. Image Credit: ktsdesign / Shutterstock

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19). Non-hospitalized people with mild or moderate cases of COVID-19 are to be enrolled at …

NIH to conduct large trial for COVID-19 polyclonal antibody therapies Read More »

Temple, Case Western scientists receive $3 million NIH grant to study pathway behind heart failure

Temple, Case Western scientists receive $3 million NIH grant to study pathway behind heart failure

Like a bad water pump that fails to circulate coolant in a car engine, a failing heart struggles to pump blood through the body, causing symptoms of fatigue, shortness of breath, and swelling in the legs and feet. As heart failure progresses, the heart itself becomes increasingly unable to contract effectively, owing to changes in …

Temple, Case Western scientists receive $3 million NIH grant to study pathway behind heart failure Read More »

SARS-COV-2 , COVID-19

NIH begins large clinical trial to test immune modulators for treatment of COVID-19

NIH begins large clinical trial to test immune modulators for treatment of COVID-19 NIH begins large clinical trial to test immune modulators for treatment of COVID-19 Colorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (yellow), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility …

NIH begins large clinical trial to test immune modulators for treatment of COVID-19 Read More »

NIH launches trial of antibody drugs against COVID-19

NIH launches trial of antibody drugs against COVID-19

NIH launches trial of antibody drugs against COVID-19 NIH launches trial of antibody drugs against COVID-19 (HealthDay)—A study to assess whether certain approved or experimental drugs are effective against COVID-19 and warrant testing in large clinical trials has been launched by the U.S. National Institutes of Health (NIH). The research will largely focus on monoclonal …

NIH launches trial of antibody drugs against COVID-19 Read More »

Promising COVID-19 rapid test technology enters phase 1 of NIH challenge

Promising COVID-19 rapid test technology enters phase 1 of NIH challenge

Promising COVID-19 rapid test technology enters phase 1 of NIH challenge Promising COVID-19 rapid test technology enters phase 1 of NIH challenge Close-up of early Rover photothermal PCR prototype, a promising new COVID-19 rapid-testing technology platform developed by Rover Diagnostics and Columbia Engineering that has been selected by the NIH to enter Phase 1 of …

Promising COVID-19 rapid test technology enters phase 1 of NIH challenge Read More »

NIH trial to test antibodies and other therapeutics for mild, moderate COVID-19

NIH trial to test antibodies and other therapeutics for mild, moderate COVID-19

NIH trial to test antibodies and other therapeutics for mild, moderate COVID-19 NIH trial to test antibodies and other therapeutics for mild, moderate COVID-19 This colorized transmission electron micrograph shows SARS-CoV-2 virus particles (orange), isolated from a patient. Credit: NIAID A Phase 2 clinical trial will evaluate the safety and efficacy of potential new therapeutics …

NIH trial to test antibodies and other therapeutics for mild, moderate COVID-19 Read More »